Intrinsic immunomodulatory effects of low-digestible carbohydrates selectively extend their anti-inflammatory prebiotic potentials

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Breton, Jérôme ^a   Plé, Coline ^a   Guerin Deremaux, Laetitia ^b   Pot, Bruno ^a   Lefranc Millot, Catherine ^b   Wils, Daniel ^b   Foligné, Benoit ^a  

^a UNIV LILLE   (France)

^b Roquette Nutritional Sciences ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; CARBOHYDRATE DERIVATIVE; CYTOKINE; FRUCTOSE; GLUCOSE; OLIGOSACCHARIDE; POLYSACCHARIDE; PREBIOTIC AGENT; TRINITROBENZENESULFONIC ACID; CARBOHYDRATE DIET;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; COLITIS; COLON FLORA; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIETARY FIBER; DRUG EFFECT; FEMALE; FERMENTATION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; ADMINISTRATION AND DOSAGE; ANIMAL; CARBOHYDRATE DIET; CHEMICALLY INDUCED; DIET THERAPY; DRUG EFFECTS; IMMUNOLOGY; INFLAMMATION; INTESTINE MUCOSA; MONONUCLEAR CELL;

MURINAE; MUS;

ANIMALS; ANTI-INFLAMMATORY AGENTS; COLITIS; DIETARY CARBOHYDRATES; DIETARY FIBER; FEMALE; HUMANS; IMMUNOMODULATION; INFLAMMATION; INTESTINAL MUCOSA; LEUKOCYTES, MONONUCLEAR; MICE; PREBIOTICS;

EID: 84929379942     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/162398     Document Type: Article

References (49)

1. S. B. Hanauer, "Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities," Inflammatory Bowel Diseases, vol. 12, supplement 1, pp. S3-S9, 2006.
2. B. Khor, A. Gardet, and R. J. Xavier, "Genetics and pathogenesis of inflammatory bowel disease," Nature, vol. 474, no. 7351, pp. 307-317, 2011.
3. C. J.Walsh, C.M.Guinane,P.W.O'Toole, andP.D. Cotter, "Beneficial modulation of the gut microbiota," FEBS Letters, 2014.
4. G. L.Hold, M. Smith, C. Grange, E. R.Watt, E. M. El-Omar, and I. Mukhopadhya, "Role of the gut microbiota in inflammatory bowel disease pathogenesis: what have we learnt in the past 10 years?" World Journal of Gastroenterology, vol. 20, no. 5, pp. 1192-1210, 2014.
5. A. W. Walker, J. D. Sanderson, C. Churcher et al., "Highthroughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease," BMC Microbiology, vol. 11, article 7, 2011.
6. F. Scaldaferri, V. Gerardi, L. R. Lopetuso et al., "Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utility," BioMed Research International, vol. 2013,Article ID 435268, 9 pages, 2013.
7. G. R. Gibson and M. B. Roberfroid, "Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics," Journal of Nutrition, vol. 125, no. 6, pp. 1401-1412, 1995.
8. G. R. Gibson, H.M. Probert, J. Van Loo, R. A. Rastall, andM. B. Roberfroid, "Dietary modulation of the human colonic microbiota: Updating the concept of prebiotics," Nutrition Research Reviews, vol. 17, no. 2, pp. 259-275, 2004.
9. G. R.Gibson, "Dietary modulation of the human gut microflora using prebiotics," British Journal of Nutrition, vol. 80, no. 4, pp. S209-S212, 1998.
10. D. M. Saulnier, J. K. Spinler, G. R. Gibson, and J. Versalovic, "Mechanisms of probiosis and prebiosis: considerations for enhanced functional foods," Current Opinion in Biotechnology, vol. 20, no. 2, pp. 135-141, 2009.
11. H. M.Hamer,D. Jonkers, K.Venema, S.Vanhoutvin, F. J. Troost, and R.-J. Brummer, "Review article: the role of butyrate on colonic function," Alimentary Pharmacology and Therapeutics, vol. 27, no. 2, pp. 104-119, 2008.
12. J. P. Segain, J. P. Galmiche, D. Raingeard de La Bletiere et al., "Butyrate inhibits inflammatory responses through NFαB inhibition: implications for Crohn's disease," Gut, vol. 47, no. 3, pp. 397-403, 2000.
13. S. Tedelind, F. Westberg, M. Kjerrulf, and A. Vidal, "Antiinflammatory properties of the short-chain fatty acids acetate and propionate: a study with relevance to inflammatory bowel disease," World Journal of Gastroenterology, vol. 13, no. 20, pp. 2826-2832, 2007.
14. M. H. Kim, S. G. Kang, J. H. Park, M. Yanagisawa, and C. H. Kim, "Short-chain fatty acids activate GPR41 and GPR43 on intestinal epithelial cells to promote inflammatory responses in mice," Gastroenterology, vol. 145, no. 2, pp. 396-e10, 2013.
15. K. M. Maslowski, A. T. Vieira, A. Ng et al., "Regulation of inflammatory responses by gut microbiota and chemoattractant receptorGPR43," Nature, vol. 461, no.7268, pp. 1282-1286,2009.
16. C. Sina, O. Gavrilova, M. Förster et al., "G protein-coupled receptor 43 is essential for neutrophil recruitment during intestinal inflammation," The Journal of Immunology, vol. 183, no. 11, pp. 7514-7522, 2009.
17. P. M. Smith, M. R. Howitt, N. Panikov et al., "The microbial metabolites, short-chain fatty acids, regulate colonic T reg cell homeostasis," Science, vol. 341, no. 6145, pp. 569-573, 2013.
18. A. P. Vos, L. M'Rabet, B. Stahl, G. Boehm, and J. Garssen, "Immune-modulatory effects and potential working mechanisms of orally applied nondigestible carbohydrates," Critical Reviews in Immunology, vol. 27, no. 2, pp. 97-140, 2007.
19. M. Roller, G. Rechkemmer, and B. Watzl, "Prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis modulates intestinal immune functions in rats," Journal of Nutrition, vol. 134, no. 1, pp. 153-156, 2004.
20. R. Kadlec and M. Jakubec, "The effect of prebiotics on adherence of probiotics," Journal of Dairy Science, vol. 97, no. 4, pp. 1983-1990, 2014.
21. M. Zenhom, A. Hyder, M. de Vrese, K. J. Heller, T. Roeder, and J. Schrezenmeir, "Prebiotic oligosaccharides reduce proinflammatory cytokines in intestinal Caco-2 cells via activation of PPARα and peptidoglycan recognition protein 3," Journal of Nutrition, vol. 141, no. 5, pp. 971-977, 2011.
22. M. Ortega-González, B. Ocón, I. Romero-Calvo et al., "Nondigestible oligosaccharides exert nonprebiotic effects on intestinal epithelial cells enhancing the immune response via activation of TLR4-NFαB," Molecular Nutrition and Food Research, vol. 58, no. 2, pp. 384-393, 2014.
23. B. Foligne, S. Nutten, C. Grangette et al., "Correlation between in vitro and in vivo immunomodulatory properties of lactic acid bacteria," World Journal of Gastroenterology, vol. 13, no. 2, pp. 236-243, 2007.
24. R. Araujo, A. G. Rodrigues, and C. Pina-Vaz, "A fast, practical and reproducible procedure for the standardization of the cell density of an Aspergillus suspension," Journal of Medical Microbiology, vol. 53, part 8, pp. 783-786, 2004.
25. B. Foligné, S. Nutten, L. Steidler et al., "Recommendations for improved use of the murine TNBS-induced colitis model in evaluating anti-inflammatory properties of lactic acid bacteria: technical and microbiological aspects," Digestive Diseases and Sciences, vol. 51, no. 2, pp. 390-400, 2006.
26. J. L. Wallace, W. K. MacNaughton, G. P. Morris, and P. L. Beck, "Inhibition of leukotriene synthesis markedly accelerates healing in a rat model of inflammatory bowel disease," Gastroenterology, vol. 96, no. 1, pp. 29-36, 1989.
27. C. K. Ameho, A. A. Adjei, E. K. Harrison et al., "Prophylactic effect of dietary glutamine supplementation on interleukin 8 and tumour necrosis factor α production in trinitrobenzene sulphonic acid induced colitis," Gut, vol. 41, no. 4, pp. 487-493, 1997.
28. P. P. Bradley, D. A. Priebat, R. D. Christensen, and G. Rothstein, "Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker," Journal of Investigative Dermatology, vol. 78, no. 3, pp. 206-209, 1982.
29. K. Matsuda, H. Tsuji, T. Asahara, K. Matsumoto, T. Takada, and K. Nomoto, "Establishment of an analytical system for the human fecal microbiota, based on reverse transcriptionquantitative PCR targeting of multicopy rRNA molecules," Applied andEnvironmentalMicrobiology, vol. 75,no. 7, pp. 1961-1969, 2009.
30. A. F. Andersson, L. Riemann, and S. Bertilsson, "Pyrosequencing reveals contrasting seasonal dynamics of taxa within Baltic Sea bacterioplankton communities," ISME Journal, vol. 4, no. 2, pp. 171-181, 2010.
31. C. de Filippo, D. Cavalieri, M. di Paola et al., "Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa," Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 33, pp. 14691-14696, 2010.
32. C. Chassard and C. Lacroix, "Carbohydrates and the human gut microbiota," Current Opinion in Clinical Nutrition and Metabolic Care, vol. 16, no. 4, pp. 453-460, 2013.
33. U. Surayot, J.Wang, P. Seesuriyachan et al., "Exopolysaccharides from lactic acid bacteria: structural analysis, molecular weight effect on immunomodulation," International Journal of Biological Macromolecules, vol. 68, pp. 233-240, 2014.
34. U. U. Nwodo, E. Green, and A. I. Okoh, "Bacterial exopolysaccharides: functionality and prospects," International Journal of Molecular Sciences, vol. 13, no. 11, pp. 14002-14015, 2012.
35. S.-M. Deutsch, S. Parayre, A. Bouchoux et al., "Contribution of surface α-Glucan polysaccharide to physicochemical and immunomodulatory properties of Propionibacterium freudenreichii," Applied and Environmental Microbiology, vol. 78, no. 6, pp. 1765-1775, 2012.
36. K. Shoaf, G. L. Mulvey, G. D. Armstrong, and R.W. Hutkins, "Prebiotic galactooligosaccharides reduce adherence of enteropathogenic Escherichia coli to tissue culture cells," Infection and Immunity, vol. 74, no. 12, pp. 6920-6928, 2006.
37. C. H. Chen, M. T. Sheu, T. F. Chen et al., "Suppression of endotoxin-induced proinflammatory responses by citrus pectin through blocking LPS signaling pathways," Biochemical Pharmacology, vol. 72, no. 8, pp. 1001-1009, 2006.
38. T. Eiwegger, B. Stahl, P. Haidl et al., "Prebiotic oligosaccharides: In vitro evidence for gastrointestinal epithelial transfer and immunomodulatory properties," Pediatric Allergy and Immunology, vol. 21, no. 8, pp. 1179-1188, 2010.
39. F. Capitán-Cañadas, M. Ortega-González, E. Guadix et al., "Prebiotic oligosaccharides directlymodulate proinflammatory cytokine production in monocytes via activation of TLR4," Molecular Nutrition and Food Research, vol. 58, no. 5, pp. 1098-1110, 2014.
40. G. D. Brown, P. R. Taylor, D.M. Reid et al., "Dectin-1 is a major α-glucan receptor on macrophages," Journal of Experimental Medicine, vol. 196, no. 3, pp. 407-412, 2002.
41. M. Bermudez-Brito, N. M. Sahasrabudhe, H. A. Schols, M. M. Faas, and P. de Vos, "Dietary fibers induce regulatory responses in human dentritic cells via modulation of inestinal epithelial cells in vitro," in Proceedings of the IEEE Photonics Conference (IPC '14), 2014.
42. J. Ruel, D. Ruane, S. Mehandru, C. Gower-Rousseau, and J.-F. Colombel, "IBD across the age spectrum - is it the same disease?" Nature Reviews Gastroenterology and Hepatology, vol. 11, no. 2, pp. 88-98, 2014.
43. S. J. Ott, M. Musfeldt, D. F. Wenderoth et al., "Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease," Gut, vol. 53, no. 5, pp. 685-693, 2004.
44. K. Machiels, M. Joossens, J. Sabino et al., "A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis," Gut, vol. 63, no. 8, pp. 1275-1283, 2013.
45. N.M. Delzenne, A. M. Neyrinck, and P. D. Cani, "Gut microbiota and metabolic disorders: how prebiotic can work?" The British Journal of Nutrition, vol. 109, supplement 2, pp. S81-S85, 2013.
46. M. Roberfroid, G. R. Gibson, L. Hoyles et al., "Prebiotic effects: metabolic and health benefits," British Journal of Nutrition, vol. 104, supplement 2, pp. S1-S63, 2010.
47. F. Emanuela,M. Grazia, D. R.Marco, L.Maria Paola, F. Giorgio, and B. Marco, "Inflammation as a link between obesity and metabolic syndrome," Journal of Nutrition andMetabolism, vol. 2012, Article ID 476380, 7 pages, 2012.
48. E. A.Murphy, J. M. Davis, M. D. Carmichael, E. P. Mayer, and A. Ghaffar, "Benefits of oat α-glucan and sucrose feedings on infection and macrophage antiviral resistance following exercise stress," The American Journal of Physiology - Regulatory Integrative and Comparative Physiology, vol. 297, no. 4, pp. R1188-R1194, 2009.
49. S. M. Kuo, "The interplay between fiber and the intestinal microbiome in the inflammatory response," Advances in Nutrition, vol. 4, no. 1, pp. 16-28, 2013.